Aiman Nisar
Company:
NuMedTechs - Nuclear Medicine & Molecular Diagnostics
Service Provided:
SEO Blog writing + infographics design
Objective:
To build a descriptive narrative of the PulmoBind biomarker’s potential.
End-goal:
Brand awareness
Lead generation (to invite strategic investment partners by exhibiting our interest in them to explore this opportunity)
Educating existing leads.
Process:
Helped in brand awareness, launching revolutionary tech ‘PulmoBind’ by writing a descriptive blog article (compelling and SEO-friendly) and crafting eye-catching infographics for the readers' visual appeal.
Additional work:
▪ I collaborated with their website developer in building a website, designing the company's logo, advising on landing page design, brand color, and tone as per reader's psychology, & and user experience
▪ I also advised on B2B content marketing, social media marketing, and sales funnel-building tips
Results:
✅ Prospects (govt. organizations in Indonesia, Singapore, and India showed partnership interest) and leads (from Europe and the US reached out).
✅ One lead offered to invest $6M for climate change PulmoBind application research (excluding others).
✅ Blog post ranked on the first page of Google for primary keyword: "Pulmobind biomarker"
✅ NuMedTechs moved beyond Pulmobind.
✅ NuMedTechs expanded into pioneering an industry-disruptive NMMI diagnostic technology which will be the cornerstone of a pulmonary vascular disease vertical build-out. When globally scaled, it will feature up to eight (8) NMMI-type products, therapeutics, devices, and Artificial Intelligence adaptations. Independently, and in collaboration, they will exceed patient healthcare standards around the world.
Note:
The article is no longer available on the numedtechs.com.
Click below to read it:
Complements:
"You created a very informative and illustrative presentation. I like the way you approach the subject matter with references and illustrations any medical professional would appreciate for thoroughness and understanding." - M. D. Billy (CEO NuMedTechs)
"The article reads very well for both a non-scientific audience and professionals in that field. It is certainly comprehensive." - Tim Montagu (Director, Finscoms)
"Although I have no medical background, I read the article on PulmoBind Biomarker and found it very exciting and inspiring." - (Founder, CryptoX Hong Kong)
Want similar descriptive articles for your company?
Inbox me to get started.